PS

Purnima Shukla

Active Director Additional Director DIN 07123385
DIN 07123385 First appointment May 2015 Primary industry Packaging
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since May 2015
Shareholding value •••• Premium profile

About Purnima Shukla

Data last updated:

Purnima Shukla is an Additional Director at Metaarth Lifesciences Private Limited (since 2023), Director at Metaarth Finserve Private Limited (since 2022) and Director at Metaarth Asset Management Ifsc Private Limited (since 2024), and holds 3 more current directorships. The companies operate in Packaging, Internet and BFSI. The 2 current companies with reported revenue have a combined latest revenue of ₹24.3 Lakh; the largest is Metaarth Lifesciences Private Limited at ₹20.7 Lakh (FY 2023). Earlier, Purnima Shukla was a Director at Dfms Investments Private Limited (from 2015).

DIN 07123385
Primary Designation Additional Director
Industry Packaging
First Appointment 26 May 2015
Oldest Company Age 23 yrs
Largest company Metaarth Lifesciences Private Limited · ₹20.7 Lakh (FY 2023)
Combined revenue ₹24.3 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director13 Jul 20232003₹20.7 Lakh (FY 2023)Active
Metaarth Finserve Private Limited U74999UP2022PTC170376
Director07 Sep 20222022₹3.6 Lakh (FY 2023)Active
Director18 Jun 20242024Active
Metaarth Investments Private Limited U64300UP2023PTC194097
Director14 Dec 20232023Active
Dfms Pharmaceuticals Limited U33119MH2018PLC316694
Director01 Nov 20182018Active
Dfms Nidhi Limited U65999UP2017PLC089672
Director03 Feb 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dfms Investments Private Limited U74120UP2015PTC070965
Director26 May 20152015₹13.9 Lakh (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Purnima Shukla

Directorship timeline

Open interactive timeline →
Dfms Pharmaceuticals Limited
Dfms Nidhi Limited
Dfms Investments Private Limited
Metaarth Finserve Private Limited
Premium access

Shareholding and investment profile for Purnima Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Purnima Shukla

Purnima Shukla currently holds 6 directorships: Metaarth Lifesciences Private Limited (Additional Director, since 13 Jul 2023, revenue ₹20.7 Lakh (FY 2023)); Metaarth Finserve Private Limited (Director, since 07 Sep 2022, revenue ₹3.6 Lakh (FY 2023)); Metaarth Asset Management Ifsc Private Limited (Director, since 18 Jun 2024); Metaarth Investments Private Limited (Director, since 14 Dec 2023); Dfms Pharmaceuticals Limited (Director, since 01 Nov 2018); and 1 more.

Purnima Shukla was first appointed on 26 May 2015 as Director at Dfms Investments Private Limited. The most recent appointment on record is 18 Jun 2024 at Metaarth Asset Management Ifsc Private Limited.

The 2 current companies of Purnima Shukla that report revenue have a combined latest revenue of ₹24.3 Lakh: Metaarth Lifesciences Private Limited ₹20.7 Lakh (FY 2023); Metaarth Finserve Private Limited ₹3.6 Lakh (FY 2023).

Purnima Shukla held 1 earlier board appointment: Dfms Investments Private Limited (Director, from 26 May 2015).

The current boards of Purnima Shukla's companies include Ambrish Nath Tiwari (Metaarth Lifesciences Private Limited), Rahma Mansoori (Dfms Pharmaceuticals Limited), Ashutosh Mishra (Dfms Nidhi Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available